$50.69
0.160.32%
Pre-Market: Jul 19, 9:30 AM EDT
15 minutes delayed
Comments
Loading...
Nutrien
NTRNYSE
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Nutrien (NYSE:NTR) Stock, Analyst Ratings, Price Targets, Forecasts
Nutrien Ltd has a consensus price target of $73.42 based on the ratings of 29 analysts. The high is $93 issued by UBS on January 4, 2022. The low is $48 issued by JP Morgan on February 23, 2024. The 3 most-recent analyst ratings were released by Wells Fargo, RBC Capital, and UBS on July 16, 2024, July 15, 2024, and July 9, 2024, respectively. With an average price target of $64 between Wells Fargo, RBC Capital, and UBS, there's an implied 26.26% upside for Nutrien Ltd from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Wells Fargo
RBC Capital
UBS
Piper Sandler
Mizuho
1calculated from analyst ratings
Analyst Ratings for Nutrien
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/16/2024 | Buy Now | 30.2% | Wells Fargo | Richard Garchitorena | $68 → $66 | Maintains | Overweight | Get Alert |
| 07/15/2024 | Buy Now | 18.37% | RBC Capital | Andrew Wong | $70 → $60 | Maintains | Outperform | Get Alert |
| 07/09/2024 | Buy Now | 30.2% | UBS | Joshua Spector | $67 → $66 | Maintains | Buy | Get Alert |
| 06/11/2024 | Buy Now | 8.5% | Piper Sandler | Charles Neivert | $56 → $55 | Maintains | Underweight | Get Alert |
| 05/17/2024 | Buy Now | 10.48% | Piper Sandler | Charles Neivert | $54 → $56 | Maintains | Underweight | Get Alert |
| 05/17/2024 | Buy Now | 10.48% | Mizuho | Christopher Parkinson | $54 → $56 | Maintains | Underweight | Get Alert |
| 05/10/2024 | Buy Now | 34.15% | Wells Fargo | Richard Garchitorena | $67 → $68 | Maintains | Overweight | Get Alert |
| 05/09/2024 | Buy Now | 16.39% | Mizuho | Christopher Parkinson | $54 → $59 | Maintains | Neutral | Get Alert |
| 04/29/2024 | Buy Now | 30.2% | Berenberg | Aron Ceccarelli | $60 → $66 | Upgrade | Hold → Buy | Get Alert |
| 03/26/2024 | Buy Now | 22.31% | Jefferies | Laurence Alexander | → $62 | Initiates | → Buy | Get Alert |
| 03/01/2024 | Buy Now | — | Wolfe Research | Chris Parkinson | — | Initiates | → Outperform | Get Alert |
| 02/29/2024 | Buy Now | 6.53% | Piper Sandler | Charles Neivert | $68 → $54 | Downgrade | Neutral → Underweight | Get Alert |
| 02/26/2024 | Buy Now | 36.12% | Wells Fargo | Richard Garchitorena | $77 → $69 | Maintains | Overweight | Get Alert |
| 02/23/2024 | Buy Now | 38.09% | RBC Capital | Andrew Wong | $75 → $70 | Maintains | Outperform | Get Alert |
| 02/23/2024 | Buy Now | -5.31% | JP Morgan | Jeffrey Zekauskas | $58 → $48 | Downgrade | Neutral → Underweight | Get Alert |
| 02/01/2024 | Buy Now | 53.88% | Goldman Sachs | Adam Samuelson | $88 → $78 | Maintains | Buy | Get Alert |
| 01/19/2024 | Buy Now | 47.96% | Stifel | Vincent Anderson | $72 → $75 | Maintains | Buy | Get Alert |
| 01/12/2024 | Buy Now | 28.23% | Raymond James | Steve Hansen | $80 → $65 | Downgrade | Outperform → Market Perform | Get Alert |
| 11/14/2023 | Buy Now | 34.15% | Barclays | Benjamin Theurer | $64 → $68 | Upgrade | Underweight → Overweight | Get Alert |
| 11/06/2023 | Buy Now | 14.42% | JP Morgan | Jeffrey Zekauskas | $70 → $58 | Downgrade | Overweight → Neutral | Get Alert |
| 11/03/2023 | Buy Now | 57.82% | RBC Capital | Andrew Wong | $85 → $80 | Maintains | Outperform | Get Alert |
| 08/14/2023 | Buy Now | 34.15% | Barclays | Benjamin Theurer | $70 → $68 | Downgrade | Overweight → Underweight | Get Alert |
| 08/08/2023 | Buy Now | 67.69% | RBC Capital | Andrew Quail | → $85 | Reiterates | Outperform → Outperform | Get Alert |
| 08/07/2023 | Buy Now | 44.01% | Piper Sandler | Charles Neivert | $70 → $73 | Maintains | Neutral | Get Alert |
| 08/04/2023 | Buy Now | 44.01% | Mizuho | Christopher Parkinson | $74 → $73 | Maintains | Neutral | Get Alert |
| 07/31/2023 | Buy Now | 63.74% | TD Cowen | Michael Tupholme | $72 → $83 | Upgrade | Hold → Buy | Get Alert |
| 07/26/2023 | Buy Now | 42.04% | HSBC | Santhosh Seshadri | $81 → $72 | Maintains | Hold | Get Alert |
| 07/25/2023 | Buy Now | 38.09% | Morgan Stanley | Vincent Sinisi | $70 → $70 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/24/2023 | Buy Now | 61.77% | Wells Fargo | Richard Garchitorena | $62 → $82 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 07/19/2023 | Buy Now | 38.09% | Morgan Stanley | Vincent Sinisi | $70 → $70 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/18/2023 | Buy Now | 138.71% | Goldman Sachs | Adam Samuelson | $136 → $121 | Maintains | Buy | Get Alert |
| 06/08/2023 | Buy Now | 67.69% | B of A Securities | Steve Byrne | $94 → $85 | Maintains | Buy | Get Alert |
| 06/01/2023 | Buy Now | 38.09% | Barclays | Benjamin Theurer | $80 → $70 | Maintains | Overweight | Get Alert |
| 05/30/2023 | Buy Now | 38.09% | Morgan Stanley | Vincent Sinisi | $80 → $70 | Maintains | Equal-Weight | Get Alert |
| 05/19/2023 | Buy Now | 53.88% | JP Morgan | Jeffrey Zekauskas | $92 → $78 | Maintains | Overweight | Get Alert |
| 05/18/2023 | Buy Now | 38.09% | Piper Sandler | Charles Neivert | $82 → $70 | Maintains | Neutral | Get Alert |
| 05/17/2023 | Buy Now | -3.33% | Berenberg | Aron Ceccarelli | $92 → $49 | Downgrade | Buy → Hold | Get Alert |
| 05/16/2023 | Buy Now | 77.55% | BMO Capital | Joel Jackson | $110 → $90 | Maintains | Outperform | Get Alert |
| 05/15/2023 | Buy Now | 22.31% | Wells Fargo | Richard Garchitorena | $82 → $62 | Maintains | Equal-Weight | Get Alert |
| 05/12/2023 | Buy Now | 87.41% | RBC Capital | Andrew Quail | $100 → $95 | Maintains | Outperform | Get Alert |
| 05/12/2023 | Buy Now | 67.69% | Raymond James | Steve Hansen | → $85 | Upgrade | Market Perform → Outperform | Get Alert |
| 05/12/2023 | Buy Now | 47.96% | Mizuho | Christopher Parkinson | $79 → $75 | Maintains | Neutral | Get Alert |
| 05/12/2023 | Buy Now | 57.82% | Barclays | Benjamin Theurer | $93 → $80 | Maintains | Overweight | Get Alert |
| 05/11/2023 | Buy Now | 18.37% | Credit Suisse | Edlain Rodriguez | $70 → $60 | Reiterates | Underperform → Underperform | Get Alert |
| 04/19/2023 | Buy Now | 109.11% | Goldman Sachs | Adam Samuelson | $119 → $106 | Maintains | Buy | Get Alert |
| 04/14/2023 | Buy Now | 83.47% | Barclays | Benjamin Theurer | $95 → $93 | Maintains | Overweight | Get Alert |
| 04/12/2023 | Buy Now | 57.82% | Morgan Stanley | Vincent Sinisi | $91 → $80 | Maintains | Equal-Weight | Get Alert |
| 04/10/2023 | Buy Now | 77.55% | Scotiabank | Ben Isaacson | $95 → $90 | Upgrade | Sector Perform → Sector Outperform | Get Alert |
| 04/06/2023 | Buy Now | 95.3% | UBS | Joshua Spector | $100 → $99 | Maintains | Buy | Get Alert |
| 03/28/2023 | Buy Now | — | Erste Group | Hans Engel | — | Downgrade | Buy → Hold | Get Alert |
| 02/23/2023 | Buy Now | 81.5% | JP Morgan | Jeffrey Zekauskas | → $92 | Maintains | Overweight | Get Alert |
| 02/21/2023 | Buy Now | 117.01% | RBC Capital | Andrew Quail | $115 → $110 | Maintains | Outperform | Get Alert |
| 02/21/2023 | Buy Now | 59.79% | HSBC | Santhosh Seshadri | $83 → $81 | Maintains | Hold | Get Alert |
| 02/17/2023 | Buy Now | 61.77% | Wells Fargo | Richard Garchitorena | $80 → $82 | Maintains | Equal-Weight | Get Alert |
| 02/16/2023 | Buy Now | 97.28% | UBS | Joshua Spector | $103 → $100 | Maintains | Buy | Get Alert |
| 02/16/2023 | Buy Now | 38.09% | Credit Suisse | Edlain Rodriguez | $65 → $70 | Maintains | Underperform | Get Alert |
| 02/08/2023 | Buy Now | — | TD Securities | Michael Tupholme | — | Downgrade | Buy → Hold | Get Alert |
| 02/03/2023 | Buy Now | — | Raymond James | Steve Hansen | — | Downgrade | Outperform → Market Perform | Get Alert |
| 01/30/2023 | Buy Now | 126.87% | RBC Capital | Andrew Wong | $120 → $115 | Maintains | Outperform | Get Alert |
| 01/20/2023 | Buy Now | 69.66% | Citigroup | PJ Juvekar | $87 → $86 | Maintains | Buy | Get Alert |
| 01/19/2023 | Buy Now | 57.82% | Wells Fargo | Richard Garchitorena | → $80 | Initiates | → Equal-Weight | Get Alert |
| 01/13/2023 | Buy Now | 87.41% | JP Morgan | Jeffrey Zekauskas | $98 → $95 | Maintains | Overweight | Get Alert |
| 01/12/2023 | Buy Now | 79.52% | Mizuho | Christopher Parkinson | $93 → $91 | Maintains | Neutral | Get Alert |
| 01/11/2023 | Buy Now | 103.2% | UBS | Joshua Spector | $110 → $103 | Maintains | Buy | Get Alert |
| 01/11/2023 | Buy Now | 79.52% | Morgan Stanley | Vincent Andrews | $100 → $91 | Maintains | Equal-Weight | Get Alert |
| 01/09/2023 | Buy Now | — | Credit Suisse | Edlain Rodriguez | — | Assumes | → Underperform | Get Alert |
| 11/30/2022 | Buy Now | 83.47% | Piper Sandler | Charles Neivert | $115 → $93 | Downgrade | Overweight → Neutral | Get Alert |
| 11/17/2022 | Buy Now | 87.41% | Barclays | Benjamin Theurer | $105 → $95 | Maintains | Overweight | Get Alert |
| 11/07/2022 | Buy Now | 136.73% | RBC Capital | Andrew Wong | $135 → $120 | Maintains | Outperform | Get Alert |
| 11/04/2022 | Buy Now | 93.33% | JP Morgan | Jeffrey Zekauskas | → $98 | Maintains | Overweight | Get Alert |
| 11/04/2022 | Buy Now | 83.47% | Mizuho | Christopher Parkinson | $113 → $93 | Maintains | Neutral | Get Alert |
| 11/04/2022 | Buy Now | 117.01% | BMO Capital | Joel Jackson | $115 → $110 | Maintains | Outperform | Get Alert |
| 11/03/2022 | Buy Now | 34.15% | Credit Suisse | John Roberts | $70 → $68 | Maintains | Underperform | Get Alert |
| 11/03/2022 | Buy Now | 117.01% | Scotiabank | Ben Isaacson | → $110 | Downgrade | Sector Outperform → Sector Perform | Get Alert |
| 11/01/2022 | Buy Now | 122.92% | Mizuho | Christopher Parkinson | $124 → $113 | Maintains | Neutral | Get Alert |
| 10/14/2022 | Buy Now | 156.46% | B of A Securities | Steve Byrne | $141 → $130 | Maintains | Buy | Get Alert |
| 08/10/2022 | Buy Now | 107.14% | Barclays | Benjamin Theurer | $126 → $105 | Maintains | Overweight | Get Alert |
| 08/09/2022 | Buy Now | 117.01% | Scotiabank | Ben Isaacson | $118 → $110 | Upgrade | Sector Perform → Sector Outperform | Get Alert |
| 08/04/2022 | Buy Now | 38.09% | Credit Suisse | John Roberts | $67 → $70 | Maintains | Underperform | Get Alert |
| 07/14/2022 | Buy Now | 32.18% | Credit Suisse | John Roberts | → $67 | Initiates | → Underperform | Get Alert |
| 06/10/2022 | Buy Now | 148.57% | Barclays | Benjamin Theurer | $116 → $126 | Maintains | Overweight | Get Alert |
| 06/01/2022 | Buy Now | 128.84% | Barclays | Benjamin Theurer | → $116 | Initiates | → Overweight | Get Alert |
| 05/31/2022 | Buy Now | 146.6% | Piper Sandler | Charles Neivert | $112 → $125 | Maintains | Overweight | Get Alert |
| 05/04/2022 | Buy Now | 136.73% | JP Morgan | Jeffrey Zekauskas | → $120 | Maintains | Overweight | Get Alert |
| 04/29/2022 | Buy Now | 144.62% | Mizuho | Christopher Parkinson | $94 → $124 | Maintains | Neutral | Get Alert |
| 04/21/2022 | Buy Now | 166.32% | RBC Capital | Andrew Wong | $120 → $135 | Maintains | Outperform | Get Alert |
| 03/28/2022 | Buy Now | — | Scotiabank | Ben Isaacson | — | Downgrade | Sector Outperform → Sector Perform | Get Alert |
| 03/22/2022 | Buy Now | 148.57% | Citigroup | PJ Juvekar | $89 → $126 | Maintains | Buy | Get Alert |
| 03/17/2022 | Buy Now | 97.28% | Morgan Stanley | Vincent Andrews | $75 → $100 | Maintains | Equal-Weight | Get Alert |
| 03/16/2022 | Buy Now | 138.71% | Goldman Sachs | Adam Samuelson | $85 → $121 | Maintains | Buy | Get Alert |
| 03/07/2022 | Buy Now | 120.95% | Piper Sandler | Charles Neivert | $87 → $112 | Upgrade | Neutral → Overweight | Get Alert |
| 03/04/2022 | Buy Now | 87.41% | JP Morgan | Jeffrey Zekauskas | $85 → $95 | Maintains | Overweight | Get Alert |
| 03/01/2022 | Buy Now | 97.28% | Stifel | Vincent Anderson | $85 → $100 | Maintains | Buy | Get Alert |
| 02/22/2022 | Buy Now | 77.55% | RBC Capital | Andrew Wong | $85 → $90 | Maintains | Outperform | Get Alert |
| 02/18/2022 | Buy Now | 81.5% | Barclays | Duffy Fischer | $84 → $92 | Maintains | Overweight | Get Alert |
| 02/18/2022 | Buy Now | 55.85% | Atlantic Equities | Colin Isaac | $68 → $79 | Upgrade | Underweight → Neutral | Get Alert |
| 02/15/2022 | Buy Now | 71.63% | Mizuho | Christopher Parkinson | $75 → $87 | Maintains | Neutral | Get Alert |
| 01/10/2022 | Buy Now | 65.71% | Barclays | Duffy Fischer | $80 → $84 | Maintains | Overweight | Get Alert |
| 01/04/2022 | Buy Now | 83.47% | UBS | John Roberts | $88 → $93 | Maintains | Buy | Get Alert |
| 12/17/2021 | Buy Now | 57.82% | Piper Sandler | Charles Neivert | — | Initiates | → Neutral | Get Alert |
FAQ
What is the target price for Nutrien (NTR) stock?
The latest price target for Nutrien (NYSE:NTR) was reported by Wells Fargo on July 16, 2024. The analyst firm set a price target for $66.00 expecting NTR to rise to within 12 months (a possible 30.20% upside). 29 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Nutrien (NTR)?
The latest analyst rating for Nutrien (NYSE:NTR) was provided by Wells Fargo, and Nutrien maintained their overweight rating.
When was the last upgrade for Nutrien (NTR)?
The last upgrade for Nutrien Ltd happened on April 29, 2024 when Berenberg raised their price target to $66. Berenberg previously had a hold for Nutrien Ltd.
When was the last downgrade for Nutrien (NTR)?
The last downgrade for Nutrien Ltd happened on February 29, 2024 when Piper Sandler changed their price target from $68 to $54 for Nutrien Ltd.
When is the next analyst rating going to be posted or updated for Nutrien (NTR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Nutrien, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Nutrien was filed on July 16, 2024 so you should expect the next rating to be made available sometime around July 16, 2025.
Is the Analyst Rating Nutrien (NTR) correct?
While ratings are subjective and will change, the latest Nutrien (NTR) rating was a maintained with a price target of $68.00 to $66.00. The current price Nutrien (NTR) is trading at is $50.69, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.